2025 / 02 / 18
We’re attending at NextGen Biomed 2025
Ajinomoto Bio-Pharma Services will participate in NextGen Biomed 2025, on March 12-14, 2025.
NextGen Biomed is a conference that brings together experts from various fields, combining Biologics EU and the Oligonucleotides Society.
At the exhibition booth, we will introduce the latest technologies such as AJICAP®.
We look forward to your visit.
| Event Name | NextGen Biomed 2025 |
|---|---|
| Dates | March 12 (Wed) -14 (Fri), 2025. |
| Venue | Novotel London West, UK |
| Exhibition | Booth 63 |
Oral Presentation
| Title and Presenters | A Versatile Approach to Generating Next-Generation Antibody Conjugates Through AJICAP® Technologies Tomohiro Fujii Ph.D., a researcher at Ajinomoto Bio-Pharma Services |
|---|---|
| Abstract | To enhance ADC efficacy and reduce toxicity, site-specific conjugation and stable linkers are crucial. Our AJICAP® conjugation method uses Fc affinity peptides for precise modification, while the AJICAP® linker ensures high stability and hydrophilicity. Combining these technologies, we create high-quality ADCs with controlled DARs (1, 2, 4, 10+), expanding the therapeutic window. We will also discuss the synthesis and biological evaluation of next-generation antibody conjugates using AJICAP® technologies. |
| Date, Time and Venue | March 13(Thu), 2025 12:00 AM |